Tower Research Capital (TRC)’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Tower Research Capital (TRC)’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,958	Closed	-$55K	–	7030
2022 Q1	$55K	Buy	2,958 +1,558	+111%	+$28K	﹤0.01%	2665
2021 Q4	$30K	Sell	1,400 -6,537	-82%	-$129K	﹤0.01%	3245
2021 Q3	$147K	Buy	7,937 +2,952	+59%	+$59.4K	﹤0.01%	2085
2021 Q2	$107K	Sell	4,985 -1,821	-27%	-$37K	﹤0.01%	2371
2021 Q1	$131K	Buy	+6,806	New	+$120K	﹤0.01%	2362

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s OCDX Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 2,958 shares — an estimated $55K sold.

Tower Research Capital (TRC) first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $147K in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Tower Research Capital (TRC) reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 2,958 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $55K.
Tower Research Capital (TRC) first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Tower Research Capital (TRC)'s Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $147K in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.